Cyclooxygenase (COX)-2 expression in a rat duodenoesophageal reflux model and chemoprevention of adenocarcinoma by the selective COX-2 inhibitor nimesulide

Japanese Journal of Gastroenterology

Volumn 104, Issue 8, 2007, Pages 1183-1191

  Oyama, Katsunobu ^a   Fujimura, Takashi ^a   Ninomiya, Itasu ^a   Miyashita, Tomoharu ^a   Kinami, Shinichi ^a   Fushida, Sachio ^a   Ohta, Tetsuo ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; MESSENGER RNA; NIMESULIDE; PROSTAGLANDIN E2; SULFONAMIDE;

ADENOCARCINOMA; ANIMAL; ARTICLE; BARRETT ESOPHAGUS; BIOSYNTHESIS; DISEASE MODEL; DUODENOGASTRIC REFLUX; ESOPHAGUS; ESOPHAGUS TUMOR; GENETICS; METABOLISM; METAPLASIA; PATHOLOGY; RAT; STOMACH MUCOSA;

ADENOCARCINOMA; ANIMALS; BARRETT ESOPHAGUS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; DISEASE MODELS, ANIMAL; DUODENOGASTRIC REFLUX; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GASTRIC MUCOSA; METAPLASIA; RATS; RNA, MESSENGER; SULFONAMIDES;

EID: 34548402520     PISSN: 04466586     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Blot WJ, Devesa SS, Kneller RW, et al : Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265 ; 1287-1289 : 1991
2. Pera M, Cameron AJ, Trastek VF, et al : Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 104 ; 510-513 : 1993 (Pubitemid 23033424)
3. Menke-Pluymers MB, Schoute NW, Mulder AH, et al : Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut 33 ; 1454-1458 : 1992
4. Clark GW, Roy MK, Corcoran BA, et al : Carcinoma of the oesophagus : the time for a multidisciplinary approach? Surg Oncol 5 ; 149-164 : 1996
5. Pauli A, Trier JS, Dalton MD, et al : The histologic spectrum of Barrett's esophagus. N Engl J Med 295 ; 476-480 : 1976
6. Winters C, Spurling TJ, Chobanian SJ, et al : Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 92 ; 118-124 : 1987
7. Miwa K, Segawa M, Takano Y, et al : Induction of oesophageal and forestomach carcinomas in rats by reflux of duodenal contents. Br J Cancer 70 ; 185-189 : 1994 (Pubitemid 24247134)
8. Miwa K, Sahara H, Segawa M, et al : Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats. Int J Cancer 67 ; 269-274 : 1996 (Pubitemid 26274160)
9. Sato T, Miwa K, Sahara H, et al : The sequential model of Barrett's esophagus and adenocarcinoma by duodeno-esophageal reflux without exogenous carcinogens. Anticancer Res 22 ; 39-44 : 2002 (Pubitemid 34475273)
10. Funkhouser EM, Sharp GB : Aspirin and reduced risk of esophageal carcinoma. Cancer 76 ; 1116-1119 : 1995
11. Taketo MM : Cyclooxygenase-2 inhibitors in tumorigenesis (Part I). J Natl Cancer Inst 90 ; 1529-1536 : 1998
12. Subbaramaiah K, Telang N, Ramonetti JT, et al : Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 56 ; 4424-4429 : 1996 (Pubitemid 26330450)
13. Matsuura H, Sakaue M, Subbaramaiah K, et al : Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases. J Biol Chem 274 ; 29138-29148 : 1999 (Pubitemid 29477078)
14. Wadleigh DJ, Reddy ST, Kopp E, et al : Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J Biol Chem 275 ; 6259-6266 : 2000
15. Nishijima K, Miwa K, Miyashita T, et al : Impact of the biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats. Ann Surg 240 ; 57-67 : 2004 (Pubitemid 38808235)
16. Tujii M, Kawano S, DuBois RN : Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci 94 ; 3336-3340 : 1997 (Pubitemid 27157312)
17. Tsujii M, Kawano S, Tsuji S, et al : Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93 ; 705-716 : 1998 (Pubitemid 28257578)
18. Souza RF, Shewmake K, Beer DG, et al : Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Cancer Res 60 ; 5767-5772 : 2000
19. Zimmermann KC, Sarbia M, Weber AA, et al : Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 59 ; 198-204 : 1999 (Pubitemid 29062978)
20. Zhang F, Altorki NK, Wu YC, et al : Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats : evidence for involvement of bile acids. Gastroenterology 121 ; 1391-1399 : 2001 (Pubitemid 33140456)
21. Kaur BS, Khamnehei N, Iravani M, et al : Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus. Gastroenterology 123 ; 60-67 : 2002 (Pubitemid 34747526)
22. Li Z, Shimada Y, Kawabe A, et al : Suppression of N- nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor. Carcinogenesis 22 ; 547-551 : 2001 (Pubitemid 32288653)
23. Buttar NS, Wang KK, Leontovich O, et al : Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology 122 ; 1101-1112 : 2002 (Pubitemid 34267291)
24. Oyama K, Fujimura T, Ninomiya I, et al : A COX-2 inhibitor prevents the esophageal inflammation-metaplasia-adenocarcinoma sequence in rats. Carcinogenesis 26 ; 565-570 : 2005 (Pubitemid 41214145)